110 related articles for article (PubMed ID: 17331333)
1. Cordycepin (3'-deoxyadenosine) inhibits human platelet aggregation induced by U46619, a TXA2 analogue.
Cho HJ; Cho JY; Rhee MH; Lim CR; Park HJ
J Pharm Pharmacol; 2006 Dec; 58(12):1677-82. PubMed ID: 17331333
[TBL] [Abstract][Full Text] [Related]
2. Cordycepin (3'-deoxyadenosine) inhibits human platelet aggregation in a cyclic AMP- and cyclic GMP-dependent manner.
Cho HJ; Cho JY; Rhee MH; Park HJ
Eur J Pharmacol; 2007 Mar; 558(1-3):43-51. PubMed ID: 17229422
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effects of cordycepin (3'-deoxyadenosine), a component of Cordyceps militaris, on human platelet aggregation induced by thapsigargin.
Cho HJ; Cho JY; Rhee MH; Kim HS; Lee HS; Park HJ
J Microbiol Biotechnol; 2007 Jul; 17(7):1134-8. PubMed ID: 18051324
[TBL] [Abstract][Full Text] [Related]
4. Cordycepin-enriched WIB801C from Cordyceps militaris inhibits ADP-induced [Ca(2+)] i mobilization and fibrinogen binding via phosphorylation of IP 3R and VASP.
Lee DH; Kwon HW; Kim HH; Lim DH; Nam GS; Shin JH; Kim YY; Kim JL; Lee JJ; Kwon HK; Park HJ
Arch Pharm Res; 2015 Jan; 38(1):81-97. PubMed ID: 25001901
[TBL] [Abstract][Full Text] [Related]
5. Antiplatelet activity of carnosol is mediated by the inhibition of TXA2 receptor and cytosolic calcium mobilization.
Lee JJ; Jin YR; Lim Y; Hong JT; Kim TJ; Chung JH; Yun YP
Vascul Pharmacol; 2006 Sep; 45(3):148-53. PubMed ID: 16916624
[TBL] [Abstract][Full Text] [Related]
6. KRDS, a peptide derived from human lactotransferrin, inhibits thrombin-induced thromboxane synthesis by a cyclooxygenase-independent mechanism.
Lévy-Toledano S; Grelac F; Caen JP; Maclouf J
Thromb Haemost; 1995 May; 73(5):857-61. PubMed ID: 7482416
[TBL] [Abstract][Full Text] [Related]
7. Phenol red is a thromboxane A2/prostaglandin H2 receptor antagonist in canine lingual arteries and human platelets.
Greenberg SS; Johns A; Kleha J; Xie J; Wang Y; Bianchi J; Conley K
J Pharmacol Exp Ther; 1994 Mar; 268(3):1352-61. PubMed ID: 8138950
[TBL] [Abstract][Full Text] [Related]
8. Antiplatelet and antithrombotic effects of cordycepin-enriched WIB-801CE from Cordyceps militaris ex vivo, in vivo, and in vitro.
Kwon HW; Shin JH; Lim DH; Ok WJ; Nam GS; Kim MJ; Kwon HK; Noh JH; Lee JY; Kim HH; Kim JL; Park HJ
BMC Complement Altern Med; 2016 Dec; 16(1):508. PubMed ID: 27927214
[TBL] [Abstract][Full Text] [Related]
9. The protective effects of paclitaxel on platelet aggregation through the inhibition of thromboxane A2 synthase.
Lee JJ; Yu JY; Lee JH; Zhang WY; Kim TJ; Myung CS; Yun YP
Arch Pharm Res; 2010 Mar; 33(3):387-94. PubMed ID: 20361303
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanism of thromboxane A(2)-induced platelet aggregation. Essential role for p2t(ac) and alpha(2a) receptors.
Paul BZ; Jin J; Kunapuli SP
J Biol Chem; 1999 Oct; 274(41):29108-14. PubMed ID: 10506165
[TBL] [Abstract][Full Text] [Related]
11. Correlation between platelet aggregation and dephosphorylation of a 68 kDa protein revealed through the use of putative PKC inhibitors.
Turini ME; Gaudette DC; Holub BJ; Kirkland JB
Thromb Haemost; 1993 Oct; 70(4):648-53. PubMed ID: 7509513
[TBL] [Abstract][Full Text] [Related]
12. The phospholipase C inhibitor U73122 inhibits phorbol ester-induced platelet activation.
Lockhart LK; McNicol A
J Pharmacol Exp Ther; 1999 May; 289(2):721-8. PubMed ID: 10215645
[TBL] [Abstract][Full Text] [Related]
13. Combined administration of 5-HT2 and thromboxane A2 antagonists: effects on platelet aggregation and isolated cardiac muscle.
Shaw LA; Batey AJ; Coker SJ
Br J Pharmacol; 1997 Jul; 121(5):875-82. PubMed ID: 9222543
[TBL] [Abstract][Full Text] [Related]
14. P2X1-initiated p38 signalling enhances thromboxane A2-induced platelet secretion and aggregation.
Huang Z; Liu P; Zhu L; Li N; Hu H
Thromb Haemost; 2014 Jul; 112(1):142-50. PubMed ID: 24633352
[TBL] [Abstract][Full Text] [Related]
15. Effects of prostaglandins, cAMP, and changes in cytosolic calcium on platelet aggregation induced by a thromboxane A2 mimic (U46619).
Yun JC; Ohman KP; Gill JR; Keiser H
Can J Physiol Pharmacol; 1991 May; 69(5):599-604. PubMed ID: 1650650
[TBL] [Abstract][Full Text] [Related]
16. Mechanism for antiplatelet effect of onion: AA release inhibition, thromboxane A(2)synthase inhibition and TXA(2)/PGH(2)receptor blockade.
Moon CH; Jung YS; Kim MH; Lee SH; Baik EJ; Park SW
Prostaglandins Leukot Essent Fatty Acids; 2000 May; 62(5):277-83. PubMed ID: 10883058
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of ganodermic acid S on the thromboxane A2-signaling pathways in human platelets.
Su CY; Shiao MS; Wang CT
Biochem Pharmacol; 1999 Aug; 58(4):587-95. PubMed ID: 10413295
[TBL] [Abstract][Full Text] [Related]
18. Role for p38 mitogen-activated protein kinase in platelet aggregation caused by collagen or a thromboxane analogue.
Saklatvala J; Rawlinson L; Waller RJ; Sarsfield S; Lee JC; Morton LF; Barnes MJ; Farndale RW
J Biol Chem; 1996 Mar; 271(12):6586-9. PubMed ID: 8636072
[TBL] [Abstract][Full Text] [Related]
19. Antiaggregatory activity of 8-epi-prostaglandin F2 alpha and other F-series prostanoids and their binding to thromboxane A2/prostaglandin H2 receptors in human platelets.
Yin K; Halushka PV; Yan YT; Wong PY
J Pharmacol Exp Ther; 1994 Sep; 270(3):1192-6. PubMed ID: 7932171
[TBL] [Abstract][Full Text] [Related]
20. Alteration of release and role of adenosine diphosphate and thromboxane A2 during collagen-induced aggregation of platelets from cattle with Chediak-Higashi syndrome.
Honda N; Ohnishi K; Fujishiro T; Ikeda M; Ito K
Am J Vet Res; 2007 Dec; 68(12):1399-406. PubMed ID: 18052747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
